wordpress blog stats
Connect with us

Hi, what are you looking for?

Updated: Madras HC stays ban on e-pharmas; wait and watch game for regulation

Update on January 7:  What the e-pharmacies appealed Practo claimed that it ensures that sale and purchase records of medicines are stored, and Schedule H and H1 drugs are not sold without valid prescriptions Pharmeasy said that it acts as an intermediary to connect customers with registered retail pharmacies; that it does not stock, sell or distribute any drugs, but merely provides delivery services. The e-pharmacy further said that it does not allow the sale of Schedule X drugs even when a customer holds a valid prescription, and that 25 licensed pharmacies are currently empaneled with Pharmeasy. 1MG said that it is merely a technology platform connecting customers to retail pharmacies, and further asserted that the current law under the Drugs & Cosmetics Act and the Drugs and Cosmetics Rules, or the draft rules for online pharmacies do not prohibit online sale of medicines. Medlife said that its business is legal and operates with licenses. It has 400 pharmacies empaneled under it, with whom it undertakes retail or wholesale business. All sales on Medlife are conducted after receiving a prescription from a registered doctor. NetMeds asserted that it holds all licenses for retail and wholesale trade. Earlier on January 4:  The Madras HC, on January 2, has stayed an earlier order which banned the online sale of medicines until further notice, saying that patients would be affected if sales were banned suddenly. A division bench of Justice M Sathyanarayanan and Justice P Rajamanickam granted the interim stay Why Madras HC…

Please subscribe/login to read the full story.
Written By

I cover health, policy issues such as intermediary liability, data governance, internet shutdowns, and more. Hit me up for tips.

MediaNama’s mission is to help build a digital ecosystem which is open, fair, global and competitive.

Views

News

India's smartphone operating system BharOS has received much buzz in the media lately, but does it really merit this attention?

News

After using the Mapples app as his default navigation app for a week, Sarvesh draws a comparison between Google Maps and Mapples

News

In the case of the ‘deemed consent' provision in the draft data protection law, brevity comes at the cost of clarity and user protection

News

The regulatory ambivalence around an instrument so essential to facilitate data exchange – the CM framework – is disconcerting for several reasons.

News

The provisions around grievance redressal in the Data Protection Bill "stands to be dangerously sparse and nugatory on various counts."

You May Also Like

News

Google has released a Google Travel Trends Report which states that branded budget hotel search queries grew 179% year over year (YOY) in India, in...

Advert

135 job openings in over 60 companies are listed at our free Digital and Mobile Job Board: If you’re looking for a job, or...

News

By Aroon Deep and Aditya Chunduru You’re reading it here first: Twitter has complied with government requests to censor 52 tweets that mostly criticised...

News

Rajesh Kumar* doesn’t have many enemies in life. But, Uber, for which he drives a cab everyday, is starting to look like one, he...

MediaNama is the premier source of information and analysis on Technology Policy in India. More about MediaNama, and contact information, here.

© 2008-2021 Mixed Bag Media Pvt. Ltd. Developed By PixelVJ

Subscribe to our daily newsletter
Name:*
Your email address:*
*
Please enter all required fields Click to hide
Correct invalid entries Click to hide

© 2008-2021 Mixed Bag Media Pvt. Ltd. Developed By PixelVJ